Kevin Haynes
Overview
Explore the profile of Kevin Haynes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
3421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newbern E, Wildisen L, Verstraeten R, Willame C, Haynes K, Levitan B, et al.
Pharmacoepidemiol Drug Saf
. 2025 Jan;
34(2):e70099.
PMID: 39887891
Purpose: With the introduction of COVID-19 vaccines, there has been a proliferation of quantitative benefit-risk assessments (qBRAs). Prior work on other types of vaccines has found that published qBRAs have...
2.
Rege S, Parlett L, Neikirk A, Iizuka A, Yang Y, Huang C, et al.
J Clin Rheumatol
. 2024 Dec;
31(1):40-44.
PMID: 39705125
Background/objective: Little is known about the rates of rheumatic disease diagnosis among children during the COVID-19 pandemic. We examined the impact of the pandemic on the diagnosis of juvenile idiopathic...
3.
Fleurence R, Kent S, Adamson B, Tcheng J, Balicer R, Ross J, et al.
Value Health
. 2024 Jun;
27(6):692-701.
PMID: 38871437
This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data...
4.
Makadia R, Shoaibi A, Rao G, Ostropolets A, Rijnbeek P, Voss E, et al.
JAMIA Open
. 2023 Nov;
6(4):ooad096.
PMID: 38028730
Objective: Developing accurate phenotype definitions is critical in obtaining reliable and reproducible background rates in safety research. This study aims to illustrate the differences in background incidence rates by comparing...
5.
Simon S, Stephenson J, Haynes K, Kennedy E, Frydman G, Amdur A, et al.
J Clin Sleep Med
. 2023 Oct;
20(3):407-416.
PMID: 37882633
Study Objectives: Although treatment of obstructive sleep apnea (OSA) with positive airway pressure (PAP) therapy is effective, adherence is often poor. Understanding the patient perspective is needed to inform adherence-promoting...
6.
Horton D, Yang Y, Neikirk A, Huang C, Crystal S, Davidow A, et al.
J Clin Rheumatol
. 2023 Oct;
29(8):388-395.
PMID: 37798830
Background/objective: Given limited information on health care and treatment utilization for juvenile idiopathic arthritis (JIA) during the pandemic, we studied JIA-related health care and treatment utilization in a commercially insured...
7.
Long M, Parlett L, Lewis J, Haynes K, Adimadhyam S, Hou L, et al.
Inflamm Bowel Dis
. 2023 Aug;
30(8):1345-1352.
PMID: 37611117
Background And Aims: Immunosuppressed individuals are at higher risk for COVID-19 complications, yet data in patients with inflammatory bowel disease (IBD) are limited. We evaluated the risk of COVID-19- severe...
8.
Andreyeva E, Chi W, Zhang Y, Kaushal R, Haynes K
Am J Manag Care
. 2023 Jul;
29(7):e199-e207.
PMID: 37523452
Objectives: To assess the impact of adding neighborhood social determinants of health (SDOH) data to demographic and clinical characteristics for predicting high-cost utilizers and to examine variations across age groups....
9.
Lewis J, Parlett L, Jonsson Funk M, Brensinger C, Pate V, Wu Q, et al.
Gastroenterology
. 2023 Jul;
165(5):1197-1205.e2.
PMID: 37481117
Background & Aims: We sought to estimate the incidence, prevalence, and racial-ethnic distribution of physician-diagnosed inflammatory bowel disease (IBD) in the United States. Methods: The study used 4 administrative claims...
10.
Adimadhyam S, Lewis J, Simon A, Wolfe A, Smith S, Hou L, et al.
Inflamm Bowel Dis
. 2023 Jun;
30(4):554-562.
PMID: 37358904
Background: Antitumor necrosis factor (anti-TNF) inhibitors are first-line treatment among patients with ulcerative colitis (UC). With time, patients tend to lose response or become intolerant, necessitating switching to small cell...